A citation-based method for searching scientific literature

Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli, Jessica Read, Peter Langmuir, Anderson J Ryan, Martin J Schlumberger. J Clin Oncol 2012
Times Cited: 839







List of co-cited articles
820 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.
N Jewel Samadder, Scott K Kuwada, Kenneth M Boucher, Kathryn Byrne, Priyanka Kanth, Wade Samowitz, David Jones, Sean V Tavtigian, Michelle Westover, Therese Berry,[...]. JAMA Oncol 2018
33
3

Findings from the Peutz-Jeghers syndrome registry of uruguay.
Asadur Tchekmedyian, Christopher I Amos, Sherri J Bale, Dakai Zhu, Stefan Arold, Joaquin Berrueta, Natalie Nabon, Thomas McGarrity. PLoS One 2013
11
9



Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.
Graeme Eisenhofer, Graham Rivers, Alejandro L Rosas, Zena Quezado, William M Manger, Karel Pacak. Drug Saf 2007
79
1

Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer.
Philip S Bernard, Whitney Wooderchak-Donahue, Mei Wei, Steven M Bray, Kevin C Wood, Baiju Parikh, Gwendolyn A McMillin. Cancers (Basel) 2021
1
100

Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.
Volker M Lauschke, Lili Milani, Magnus Ingelman-Sundberg. AAPS J 2017
69
1

APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer.
Noritaka Tanaka, Tetsuo Mashima, Anna Mizutani, Ayana Sato, Aki Aoyama, Bo Gong, Haruka Yoshida, Yukiko Muramatsu, Kento Nakata, Masaaki Matsuura,[...]. Mol Cancer Ther 2017
53
1

Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study.
Sean P Cleary, Michelle Cotterchio, Mark A Jenkins, Hyeja Kim, Robert Bristow, Roger Green, Robert Haile, John L Hopper, Loic LeMarchand, Noralane Lindor,[...]. Gastroenterology 2009
139
1

Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
Hideki Ishikawa, Michihiro Mutoh, Yasushi Sato, Hisashi Doyama, Masahiro Tajika, Shinji Tanaka, Takahiro Horimatsu, Yoji Takeuchi, Hiroshi Kashida, Jun Tashiro,[...]. Lancet Gastroenterol Hepatol 2021
11
9

Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids.
Amirsaeed Sabeti Aghabozorgi, Mostafa Moradi Sarabi, Reza Jafarzadeh-Esfehani, Shabnaz Koochakkhani, Marziyeh Hassanzadeh, Soudabeh Kavousipour, Ebrahim Eftekhar. World J Gastrointest Oncol 2020
5
20

Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis.
S Iodice, M Barile, N Rotmensz, I Feroce, B Bonanni, P Radice, L Bernard, P Maisonneuve, S Gandini. Eur J Cancer 2010
124
1

Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.
J R Howe, J L Bair, M G Sayed, M E Anderson, F A Mitros, G M Petersen, V E Velculescu, G Traverso, B Vogelstein. Nat Genet 2001
448
1

Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes.
Thierry Frebourg, Svetlana Bajalica Lagercrantz, Carla Oliveira, Rita Magenheim, D Gareth Evans. Eur J Hum Genet 2020
68
1

Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients.
T Byrski, T Huzarski, R Dent, E Marczyk, M Jasiowka, J Gronwald, J Jakubowicz, C Cybulski, R Wisniowski, D Godlewski,[...]. Breast Cancer Res Treat 2014
162
1


Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells.
S Aebi, D Fink, R Gordon, H K Kim, H Zheng, J L Fink, S B Howell. Clin Cancer Res 1997
154
1

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, Matthew D Hellmann, Mark M Awad, Justin F Gainor, Alexa B Schrock, Ryan J Hartmaier, Sally E Trabucco, Laurie Gay,[...]. Cancer Discov 2018
660
1

Targeting NAD+/PARP DNA Repair Pathway as a Novel Therapeutic Approach to SDHB-Mutated Cluster I Pheochromocytoma and Paraganglioma.
Ying Pang, Yanxin Lu, Veronika Caisova, Yang Liu, Petra Bullova, Thanh-Truc Huynh, Yiqiang Zhou, Di Yu, Zdenek Frysak, Igor Hartmann,[...]. Clin Cancer Res 2018
39
2


Glioblastoma following radiotherapy in a patient with tuberous sclerosis.
H Matsumura, H Takimoto, N Shimada, M Hirata, T Ohnishi, T Hayakawa. Neurol Med Chir (Tokyo) 1998
39
2

Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, Steven Coutre, John F Seymour, Talha Munir, Soham D Puvvada, Clemens-Martin Wendtner, Andrew W Roberts, Wojciech Jurczak,[...]. Lancet Oncol 2016
517
1

Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.
Ferdinandos Skoulidis, Lauren A Byers, Lixia Diao, Vassiliki A Papadimitrakopoulou, Pan Tong, Julie Izzo, Carmen Behrens, Humam Kadara, Edwin R Parra, Jaime Rodriguez Canales,[...]. Cancer Discov 2015
468
1

p53 in health and disease.
Karen H Vousden, David P Lane. Nat Rev Mol Cell Biol 2007
1

Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.
Aung Ko Win, Mark A Jenkins, James G Dowty, Antonis C Antoniou, Andrew Lee, Graham G Giles, Daniel D Buchanan, Mark Clendenning, Christophe Rosty, Dennis J Ahnen,[...]. Cancer Epidemiol Biomarkers Prev 2017
173
1

Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235.
Pieter J A Eichhorn, Magüi Gili, Maurizio Scaltriti, Violeta Serra, Marta Guzman, Wouter Nijkamp, Roderick L Beijersbergen, Vanesa Valero, Joan Seoane, René Bernards,[...]. Cancer Res 2008
382
1


SMAD4 levels and response to 5-fluorouracil in colorectal cancer.
Pia Alhopuro, Hafid Alazzouzi, Heli Sammalkorpi, Verónica Dávalos, Reijo Salovaara, Akseli Hemminki, Heikki Järvinen, Jukka-Pekka Mecklin, Simo Schwartz, Lauri A Aaltonen,[...]. Clin Cancer Res 2005
68
1

HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma.
Kevin D Courtney, Yuanqing Ma, Alberto Diaz de Leon, Alana Christie, Zhiqun Xie, Layton Woolford, Nirmish Singla, Allison Joyce, Haley Hill, Ananth J Madhuranthakam,[...]. Clin Cancer Res 2020
62
1

PTEN Loss Mediates Clinical Cross-Resistance to CDK4/6 and PI3Kα Inhibitors in Breast Cancer.
Carlotta Costa, Ye Wang, Amy Ly, Yasuyuki Hosono, Ellen Murchie, Charlotte S Walmsley, Tiffany Huynh, Christopher Healy, Rachel Peterson, Shogo Yanase,[...]. Cancer Discov 2020
76
1

Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.
Aung Ko Win, Jeanette C Reece, James G Dowty, Daniel D Buchanan, Mark Clendenning, Christophe Rosty, Melissa C Southey, Joanne P Young, Sean P Cleary, Hyeja Kim,[...]. Int J Cancer 2016
64
1

Mismatch repair proficiency and in vitro response to 5-fluorouracil.
J M Carethers, D P Chauhan, D Fink, S Nebel, R S Bresalier, S B Howell, C R Boland. Gastroenterology 1999
343
1

Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.
Driss Ait Ouakrim, Seyedeh Ghazaleh Dashti, Rowena Chau, Daniel D Buchanan, Mark Clendenning, Christophe Rosty, Ingrid M Winship, Joanne P Young, Graham G Giles, Barbara Leggett,[...]. J Natl Cancer Inst 2015
57
1

Platinum resistance: the role of DNA repair pathways.
Lainie P Martin, Thomas C Hamilton, Russell J Schilder. Clin Cancer Res 2008
522
1

Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
Sosipatros A Boikos, Alberto S Pappo, J Keith Killian, Michael P LaQuaglia, Chris B Weldon, Suzanne George, Jonathan C Trent, Margaret von Mehren, Jennifer A Wright, Josh D Schiffman,[...]. JAMA Oncol 2016
171
1

Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer.
Shuyan Sheng, Ye Xu, Yonghai Guo, Lu Yao, Li Hu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan,[...]. Int J Cancer 2020
6
16

Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers.
Peter C Elwood, Gareth Morgan, Christine Delon, Majd Protty, Julieta Galante, Janet Pickering, John Watkins, Alison Weightman, Delyth Morris. Ecancermedicalscience 2021
4
25

Inherited TP53 Mutations and the Li-Fraumeni Syndrome.
Tanya Guha, David Malkin. Cold Spring Harb Perspect Med 2017
80
1

Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation.
Diana Pinto, Carla Pinto, Joana Guerra, Manuela Pinheiro, Rui Santos, Hege Marie Vedeld, Zeremariam Yohannes, Ana Peixoto, Catarina Santos, Pedro Pinto,[...]. Cancer Med 2018
19
5

Chemoprevention in familial adenomatous polyposis: past, present and future.
Phillip M Kemp Bohan, Gautam Mankaney, Timothy J Vreeland, Robert C Chick, Diane F Hale, Jessica L Cindass, Annelies T Hickerson, Daniel C Ensley, Vance Sohn, G Travis Clifton,[...]. Fam Cancer 2021
9
11

Targeting renal cell carcinoma with a HIF-2 antagonist.
Wenfang Chen, Haley Hill, Alana Christie, Min Soo Kim, Eboni Holloman, Andrea Pavia-Jimenez, Farrah Homayoun, Yuanqing Ma, Nirav Patel, Paul Yell,[...]. Nature 2016
371
1

Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study.
Joanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, Pal Moller, Henry T Lynch, Susan L Neuhausen, Leigha Senter, Rochelle Demsky, William D Foulkes, Charis Eng,[...]. Breast Cancer Res Treat 2016
36
2

Wnt/β-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells.
Felipe Nuñez, Soraya Bravo, Fernando Cruzat, Martín Montecino, Giancarlo V De Ferrari. PLoS One 2011
81
1

Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation.
Lotte Bjerre Knudsen, Lars Wichmann Madsen, Søren Andersen, Kasper Almholt, Anne S de Boer, Daniel J Drucker, Carsten Gotfredsen, Frederikke Lihme Egerod, Anne Charlotte Hegelund, Helene Jacobsen,[...]. Endocrinology 2010
352
1



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.